Acumen Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 14.93 M | $25.68 M | 0.00% | 24.85% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 3.42 M | $5.88 M | 0.00% | 5.69% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 3.27 M | $5.63 M | -7.76% | 5.45% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.37 M | $4.08 M | 1.74% | 3.95% |
| FMR LLC | 02/13/2025 | 2.02 M | $3.48 M | -0.21% | 3.37% |
| VANGUARD GROUP INC | 02/11/2025 | 1.94 M | $3.34 M | 0.35% | 3.23% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.84 M | $3.16 M | -20.05% | 3.06% |
| KNOLLWOOD INVESTMENT ADVISORY, LLC | 02/14/2025 | 1.63 M | $2.80 M | 0.00% | 2.71% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 1.34 M | $2.31 M | -26.71% | 2.24% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 939,603 | $1.62 M | 0.00% | 1.56% |
| JPMORGAN CHASE & CO | 02/12/2025 | 937,908 | $1.61 M | 1,387.18% | 1.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 870,555 | $1.50 M | 0.70% | 1.45% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 867,046 | $1.49 M | 0.00% | 1.44% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 715,000 | $1.23 M | 12.42% | 1.19% |
| PATHSTONE HOLDINGS, LLC | 02/14/2025 | 606,845 | $1.04 M | 17.31% | 1.01% |
| STATE STREET CORP | 02/14/2025 | 525,806 | $904,386 | 1.82% | 0.88% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 499,100 | $858,452 | 6.40% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 301,268 | $518,181 | -2.66% | 0.50% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 265,769 | $457,123 | -0.25% | 0.44% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 257,213 | $442,406 | -15.97% | 0.43% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 219,144 | $376,928 | 50.24% | 0.36% |
| UBS GROUP AG | 02/14/2025 | 141,492 | $243,367 | 521.92% | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 134,000 | $230,480 | -2.47% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 126,747 | $218,005 | 16.56% | 0.21% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 98,016 | $168,588 | 73.31% | 0.16% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 96,995 | $166,831 | 468.72% | 0.16% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 94,294 | $162,186 | 100.00% | 0.16% |
| BARCLAYS PLC | 02/13/2025 | 93,082 | $161,000 | 50.14% | 0.15% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 92,983 | $159,930 | 0.00% | 0.15% |
| CATALYST FINANCIAL PARTNERS LLC | 01/30/2025 | 89,699 | $154,282 | 0.00% | 0.15% |
| CITIGROUP INC | 02/12/2025 | 80,345 | $138,193 | 162.63% | 0.13% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 78,446 | $134,927 | 0.00% | 0.13% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 75,888 | $130,527 | 40.48% | 0.13% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 68,321 | $117,512 | -17.39% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 54,278 | $93,358 | -0.49% | 0.09% |
| RHUMBLINE ADVISERS | 01/30/2025 | 53,076 | $91,284 | -40.02% | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 51,042 | $87,792 | -1.29% | 0.09% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 48,414 | $83,272 | -7.64% | 0.08% |
| ATOM INVESTORS LP | 02/14/2025 | 33,678 | $57,926 | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 33,100 | $56,932 | 56.87% | 0.06% |
| JANE STREET GROUP, LLC | 02/14/2025 | 30,740 | $52,872 | -93.70% | 0.05% |
| INTREPID FINANCIAL PLANNING GROUP LLC | 02/10/2025 | 30,150 | $51,858 | 0.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 28,848 | $49,619 | -76.47% | 0.05% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 26,119 | $44,925 | 22.87% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 24,079 | $41,416 | 4.62% | 0.04% |
| SEI INVESTMENTS CO | 02/11/2025 | 21,782 | $37,465 | 0.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 20,855 | $35,871 | -7.02% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 20,624 | $35,473 | 427.47% | 0.03% |
| INVESCO LTD. | 02/13/2025 | 19,842 | $34,128 | 9.09% | 0.03% |
| VERITION FUND MANAGEMENT LLC | 02/14/2025 | 19,445 | $33,445 | 100.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acumen Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 89 institutional investors and hedge funds held shares of Acumen Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 14.93 M
Sands Capital Ventures, LLC: 3.42 M
FRANKLIN RESOURCES INC: 3.27 M
BlackRock Funding, Inc. /DE: 2.37 M
FMR LLC: 2.02 M
VANGUARD GROUP INC: 1.94 M
70.73% of Acumen Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 45.23 M shares in the last 24 months. This purchase volume represents approximately $83.68 M in transactions.